Literature DB >> 30642603

The bacterial and fungal microbiome of the skin of healthy dogs and dogs with atopic dermatitis and the impact of topical antimicrobial therapy, an exploratory study.

Suttiwee Chermprapai1, Thomas H A Ederveen2, Femke Broere3, Els M Broens4, Yvette M Schlotter5, Saskia van Schalkwijk6, Jos Boekhorst7, Sacha A F T van Hijum8, Victor P M G Rutten9.   

Abstract

Canine atopic dermatitis is a genetically predisposed inflammatory and pruritic allergic skin disease that is often complicated by (secondary) bacterial and fungal (yeast) infections. High-throughput DNA sequencing was used to characterize the composition of the microbiome (bacteria and fungi) inhabiting specific sites of skin in healthy dogs and dogs with atopic dermatitis (AD) before and after topical antimicrobial treatment. Skin microbiome samples were collected from six healthy control dogs and three dogs spontaneously affected by AD by swabbing at (non-) predilection sites before, during and after treatment. Bacteria and fungi were profiled by Illumina sequencing of the 16S ribosomal RNA gene of bacteria (16S) and the internally transcribed spacer of the ribosomal gene cassette in fungi (ITS). The total cohort of dogs showed a high diversity of microbes on skin with a strong individual variability of both 16S and ITS profiles. The genera of Staphylococcus and Porphyromonas were dominantly present both on atopic and healthy skin and across all skin sites studied. In addition, bacterial and fungal alpha diversity were similar at the different skin sites. The topical antimicrobial treatment increased the diversity of bacterial and fungal compositions in course of time on both AD and healthy skin.
Copyright © 2018 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  16S; ITS; atopic dermatitis; canine; microbiome composition; topical treatment

Mesh:

Substances:

Year:  2018        PMID: 30642603     DOI: 10.1016/j.vetmic.2018.12.022

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  7 in total

1.  Characterization of microbiota diversity of engorged ticks collected from dogs in China.

Authors:  Seongjin Wang; Xiuguo Hua; Li Cui
Journal:  J Vet Sci       Date:  2021-05       Impact factor: 1.672

2.  Recombinant human interferon-α14 for the treatment of canine allergic pruritic disease in eight dogs.

Authors:  Breno C B Beirão; Aline C Taraciuk; Carolina Trentin; Max Ingberman; Luiz F Caron; Chris McKenzie; William H Stimson
Journal:  Vet Rec Open       Date:  2021-05-02

3.  A descriptive study of allergen-specific IgE serological tests for canine atopic dermatitis in Thailand.

Authors:  Suttiwee Chermprapai; Naris Thengchaisri
Journal:  BMC Vet Res       Date:  2020-12-07       Impact factor: 2.741

4.  Efficacy of Antimicrobial Treatment in Dogs with Atopic Dermatitis: An Observational Study.

Authors:  Evi I Sofou; Svetlina Aleksandrova; Elisa Badulescu; Manolis Chatzis; Manolis Saridomichelakis
Journal:  Vet Sci       Date:  2022-07-27

5.  Fresh Food Consumption Increases Microbiome Diversity and Promotes Changes in Bacteria Composition on the Skin of Pet Dogs Compared to Dry Foods.

Authors:  Kennedy Leverett; Rodrigo Manjarín; Erica Laird; Diana Valtierra; Tasha M Santiago-Rodriguez; Renan Donadelli; Gerardo Perez-Camargo
Journal:  Animals (Basel)       Date:  2022-07-22       Impact factor: 3.231

6.  Vishniacozyma victoriae (syn. Cryptococcus victoriae) in the homes of asthmatic and non-asthmatic children in New York City.

Authors:  Rachael E Rush; Karen C Dannemiller; Samuel J Cochran; Sarah R Haines; Luis Acosta; Adnan Divjan; Andrew G Rundle; Rachel L Miller; Matthew S Perzanowski; Tara L Croston; Brett J Green
Journal:  J Expo Sci Environ Epidemiol       Date:  2021-06-05       Impact factor: 5.563

7.  Impact of the early-life skin microbiota on the development of canine atopic dermatitis in a high-risk breed birth cohort.

Authors:  S Rodriguez-Campos; A Rostaher; L Zwickl; N Fischer; I Brodard; S Vidal; B W Brandt; C Favrot; V Perreten
Journal:  Sci Rep       Date:  2020-01-23       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.